Targeting imperfect vaccines against drug-resistance determinants: a strategy for countering the rise of drug resistance.
The growing prevalence of antimicrobial resistance in major pathogens is outpacing discovery of new antimicrobial classes. Vaccines mitigate the effect of antimicrobial resistance by reducing the need for treatment, but vaccines for many drug-resistant pathogens remain undiscovered or have limited e...
Main Authors: | Regina Joice, Marc Lipsitch |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3723804?pdf=render |
Similar Items
-
Insights on recent approaches in drug discovery strategies and untapped drug targets against drug resistance
by: Ramalingam Peraman, et al.
Published: (2021-03-01) -
Sex, drugs and superbugs: The rise of drug resistant STIs
by: Alex Broom, et al.
Published: (2023-12-01) -
New treatments for Drug Resistant TB: Past imperfect, future bright
by: Zarir F Udwadia, et al.
Published: (2023-01-01) -
Multi-epitope chimeric vaccine designing and novel drug targets prioritization against multi-drug resistant Staphylococcus pseudintermedius
by: Samavia Jaan, et al.
Published: (2022-08-01) -
Partnering on vaccines to counter multi-drug resistant threats: Workshop proceedings, Biomedical Advanced Research and Development Authority
by: Julie N. Bergmann, et al.
Published: (2022-11-01)